Dr Jonathan Repple
In this Q&A, Jonathan Repple, MD, professor of predictive psychiatry at the University of Frankfurt, Germany, discussed his most recent study presented on a poster at the 3
Monica Gandhi, MD, MPH, infectious disease doctor and director of the Center for AIDS Research at University of California–San Francisco, discusses medication therapies in the pipeline that could change the...
Elizabeth Volkmann, MD, associate professor at UCLA, Director of the Scleroderma Program, and the codirector of UCLA's Connective Tissue Disease-Related Interstitial Lung Disease program, discusses treating...
Joshua Richter, MD, associate professor of medicine, hematology, and oncology, Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai, reviews real-world data presented at the SOHO 2022 Annual...
The continuation of proper care once a patient with sepsis is discharged from the hospital is critical in reducing the risk of rehospitalization and mortality. Stephanie Parks Taylor, MD, answers our...
As influenza vaccination rates among health care workers often fall at substandard levels, mandatory vaccination has been proposed. In this Q&A, Gianluca Voglino, MD, discusses his team’s findings on the...
Jonathon O. Russell, MD, answers our questions about his new study, which found that magnesium disorders may be a modifiable target in reducing the incidence of hypocalcemia after total thyroidectomy.
New research sheds light on a novel biomarker that may accurately predict new-onset peripheral arterial disease in patients with mild to moderate chronic kidney disease. Researcher Scott E. Janus, MD,...
